The Carnot Institute CALYM and CRYOSTEM have been collaborating since 2020 to develop a new collection of biological resources (blood, stool and urine) from lymphoma patients treated with CAR-T cells (Chimeric Antigen Receptor-T).

This collection of great biological and clinical added value allows scientists to accelerate the development of innovative treatments and diagnostic tools to fight the disease.To learn more about the CeVi CAR-T collection discover the new article

LinkedIn article